The main focus areas include regulatory B cells, ocrelizumab, neurodegeneration, demyelination, Epstein-Barr virus, laquinimod, myelin oligodendrocyte glycoprotein, gut microbiota, neuromyelitis optica, and dimethyl fumarate, highlighting the field’s knowledge structure and diversity. The gene discussed is OMG; the disease is neuromyelitis optica.